Samsung Biologics Webinars

11. Biopharmaceutical Process Characterization

    Here we present process development and characterization strategies required to support commercial scale manufacture of antibody therapeutics. 

12. Accelerated Tech Transfer For A COVID-19 Program

    This webinar describes the acceleration of tech transfer to enable kickoff to vial thaw for antibody manufacture within three months for a clinical program and five months for  process qualification.

13. Continuous Manufacturing: Challenges, Advantages Of N-1 Perfusion

    Discover key considerations and challenges in implementing N-1 perfusion technology, as well as the impact of continuous technology on tech transfer and process scale-up.

14. How COVID-19 Is Redefining Drug Development And Manufacturing

    Unprecedented times provide opportunities to advance innovative technology, establish a robust business contingency plan, and reduce lead time to drug delivery.